Change to Yellow Card reporting in children

The MHRA no longer requires all suspected adverse drug reactions (ADRs) in children and adolescents to be reported.

The quickest ADR reporting method is online but a paper copy of the Yellow Card form can alternatively be posted to the MHRA. | SCIENCE PHOTO LIBRARY

This change has been made in response to feedback that mandatory reporting of all suspected ADRs in children was impractical and deterred reporting. The advice for reporting adverse reactions is now the same for adults and children.

When to report

A Yellow Card needs to be completed for any ADR that is:

  • serious or results in harm and/or
  • associated with newer drugs and vaccines identified by the black triangle symbol (▼).

A serious reaction is one that is fatal, life-threatening, disabling or incapacitating, causes a congenital abnormality or results in hospitalisation, or is medically significant for any other reason.

ADRs meeting the above criteria should be reported if they are suspected to be caused by medicines, vaccines, herbal or complementary products, including from misuse or overdose, or from use of unlicensed or off-label medicines.

Where harm occurs as a result of a medication error, a Yellow Card may be completed or the error can be reported via the National Reporting and Learning System.

A paper copy of the Yellow Card form can be found at the back of the print issue of MIMS. This will be updated for the next quarterly edition (December) to reflect the changes to reporting ADRs in children and adolescents.

Further information: MHRA Drug Safety Update, September 2014

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...

Drug shortages - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...

Pregnant woman having an ultrasound scan with a female sonographer

Valproate prescribing: plan for new regulatory measures without delay, instructs MHRA

A National Patient Safety Alert (NatPSA) has been issued...